|
 |
Veronique Baron's
PubMed References
Egr1-related publications:
Yu J, Baron V, MercolaD, Mustelin T, Adamson ED.
A network of p73 p53
and Egr1 is required for efficient apoptosis in tumor cells.
Cell Death
Differ. (2007) 14 : 436-446
Gaggioli C, Robert G, Bertolotto C, Bailet O, Abbe, P, Spadafora A,
Ortonne JP, Baron V, Ballotti R, Tartare-Deckert S.
Tumor-derived fibronectin
is involved in melanoma cell invasion and regulated by V600E B-Raf signaling
pathway.
J Invest Dermatol. (2007) 127 : 400-410
Baron V, Adamson ED, Calogero A, Ragona, G, Mercola D.
The transcription
factor Egr-1 is a direct regulator of multiple tumor suppressors including
TGFbeta-1, PTEN, p53 and fibronectin.
Cancer Gene Therapy (2006) 13:
115-124; Review.
Baron V, De Gregorio G, Krones-Herzig A, Virolle T, Calogero A, Urcis
R, Mercola, D.
Inhibition of Egr-1 expression reverses transformation
of prostate cancer cells in vitro an in vivo.
Oncogene (2003) 22 : 4194-4204
Baron V, Duss S, Rhim J, Mercola D
Antisense to the Early Growth Response-1
Gene (Egr-1) Inhibits Prostate Tumor development in TRAMP mice.
Ann N
Y Acad Sci. (2003) 1002 : 197-216; Review
Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola
D
Egr1 promotes growth and survival of prostate cancer cells: identification
of novel Egr1 target genes.
J Biol Chem (2003) 278 : 11802-11810
Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, de Belle
I
The Egr-1 transcription factor directly activates PTEN during irradiation-induced
signaling.
Nature
Cell Biology (2001) 3 : 1124-112
Earlier selected publications:
El Annabi S, Gautier N, Baron V
Focal Adhesion Kinase and Src mediate
integrin regulation of insulin receptor phosphorylation.
FEBS lett. (2001)
507 : 247-252
Baron V, Schwartz MA
Cell adhesion regulates ubiquitin-mediated degradation
of the Platelet-Derived Growth Factor receptor-beta.
J Biol Chem (2000)
275 : 39318-39323
Lebrun P, Baron V, Hauck CR, Schlaepfer DD, Van Obberghen E
Cell adhesion
and Focal Adhesion Kinase regulate Insulin Receptor Substrate-1 expression.
J Biol Chem (2000) 275 : 38371-38377
Shiraga M, Ritchie A, Aidoudi S, Baron V, Wilox D, White GC, Ybarrando
B, Murphy GJ, Laevitt A, Shattil SJ
Primary megakaryocytes reveal a
role for transcription factor NF-E2 in integrin alphaIIb-beta3 signaling.
J Cell Biol (1999) 147 : 1419-1430
Lebrun P, Mothe-Satney I, Delahaye L, Van Obberghen E, Baron V
Insulin
Receptor Substrate-1 as a signaling molecule for focal adhesion kinase
pp125(FAK) and pp60(Src).
J Biol Chem (1998) 273 : 32244-32253
Baron V, Alengrin F, Van Obberghen E
Dynamin associates with Src-Homology
Collagen (Shc) and becomes tyrosine phosphorylated in response to insulin.
Endocrinology (1998) 139 : 3034-3037
Baron V, Calléja V, Ferrari P, Alengrin F, Van Obberghen E
p125Fak
focal adhesion kinase is a substrate for the insulin and insulin-like
growth factor-I tyrosine kinase receptors.
J Biol Chem (1998) 273 : 7162-7168
Gual P, Baron V, Lequoy V, Van Obberghen E
Interaction of Janus Kinases
JAK 1 and JAK 2 with the insulin receptor and the Insulin Like Growth
Factor-I receptor.
Endocrinology (1998) 139 : 884-893
Sawka-Verhelle D, Baron V, Mothe I, Filloux C, White MF, Van Obberghen
E
Tyr624 and Tyr628 in Insulin Receptor Substrate-2 mediate its association
with the insulin receptor.
J Biol Chem (1997) 272 : 16414-16420
Calléja V, Ruiz Enriquez P, Filloux C, Peraldi P, Baron V, Van
Obberghen E
The effect of cyclic Adenosine Monophosphate on the MAPK
pathway depends on both the cell type and the type of tyrosine kinase
receptor.
Endocrinology (1997) 138 : 1111-1120
Gual P, Baron V, Alengrin F, Mothe I, Van Obberghen E
Insulin receptor-induced
phosphorylation of cellular and synthetic substrates is regulated by
the receptor beta-subunit C-terminus.
Endocrinology (1996) 137 : 3416-3423
Gual P, Baron V, Alengrin F, Van Obberghen E
A conformational change
in the beta-subunit of the insulin-like growth factor-I receptor identified
by antipeptide antibodies.
Endocrinology (1995) 136 : 5298-5304
Kaliman P, Baron V, Alengrin F, Takata Y, Webster NJ, Olefsky JM, Van
Obberghen E
The insulin receptor C-terminus is involved in regulation
of the receptor kinase activity.
Biochemistry (1993) 32 : 9539-9544
Lebrun C, Baron V, Kaliman P, Gautier N, Dolais-Kitabgi J, Taylor S,
Accili D, Van Obberghen E: Antibodies to the extracellular receptor domain
restore the hormone-insensitive kinase and conformation of the mutant
insulin receptor Val382. J Biol Chem (1993) 268 : 11272-11277
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8388389
Baron V, Kaliman P, Gautier N, Van Obberghen E: The insulin receptor
activation process involves localized conformational changes. J Biol
Chem (1992) 267 : 23290-23294
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1331080
Tanti J-F, Gautier N, Cormont M, Baron V, Van Obberghen E, Le Marchand-Brustel
Y: Potential involvement of the carboxy-terminus of the Glut1 transporter
in glucose transport. Endocrinology (1992) 131 : 2319-2324
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1425430
Kaliman P, Baron V, Gautier N, Van Obberghen E: Antipeptide antibody
to the Insulin-like Growth Factor-I receptor sequence 1232-1246 inhibits
the receptor kinase activity. J Biol Chem (1992) 267 : 10645-10651
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1316907
Baron V, Gautier N, Kaliman P, Dolais-Kitabgi J, Van Obberghen E: The
carboxyl-terminal domain of the insulin receptor: its potential role
in growth promoting effects. Biochemistry (1991) 30 : 9365-9370
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1654097
Hainaut P, Kowalski A, Giorgetti S, Baron V, Van Obberghen E. Insulin
and insulin-like growth factor-I (IGF-I) receptors in Xenopus laevis
oocytes: comparison with insulin receptors from liver and muscle. Biochem
J (1991) 273 : 673-678
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1847619
Baron V, Gautier N, Komoriya A, Hainaut P, Scimeca JC, Mervic M, Lavielle
S, Dolais-Kitabgi J, Van Obberghen E. Insulin binding to its receptor
induces a conformational change in the receptor C-terminus. Biochemistry
(1990) 29 : 4634-4640
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2196938
Baron V, Gautier N, Rochet N, Ballotti R, Rossi B, Saint-Pierre S, Van
Obberghen E, Dolais-Kitabgi J: Antibodies to insulin receptor tyrosine
kinase stimulate its activity towards exogenous substrates without inducing
receptor autophosphorylation. Biochem J (1989) 260 : 749-756
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2764902
Ponzio G, Contreres JO, Debant A, Baron V, Gautier N, Dolais-Kitabgi
J, Rossi B: Use of an anti-insulin receptor antibody to discriminate
between metabolic and mitogenic effects of insulin: correlation with
receptor autophosphorylation. EMBO J (1988) 7 : 4111-4117
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3072194
Selected Reviews
Baron V, Lebrun P: Crosstalk between integrins and tyrosine kinase receptors
signaling pathways. Médecine/Sciences (2001) 17 : 111-114
Schwartz MA, Baron V: Interactions between mitogenic stimuli, or, a
thousand and one connections. Current Opinion in Cell Biology (1999)
11 : 197-202
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10209147
Van Obberghen E, Baron V, Delahaye L, Emanuelli B, Filippa N, Giorgetti-Peraldi
S, Lebrun P, Mothe-Satney I, Peraldi P, Rocchi S, Sawka-Verhelle D, Tartare-Deckert
S, Giudicelli J: Surfing the insulin signaling web. Eur J Clin Invest
(2001) 31 : 966-77
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11737239
|
